Arja Kuittinen
Directeur Général chez Primus International Oy Ltd.
Profil
Arja Kuittinen is currently the Chief Executive Officer at Primus International Oy Ltd.
and a Non-Executive Director at Aplagon Oy.
Previously, she worked as the Chairman at Hermo Pharma Oy, Director-Clinical Operations at Quintiles, Inc. (California), Country Manager at Hoechst Marion Roussel SA, and as a Principal at Lallemand Finland Oy and Addoz Oy.
Postes actifs de Arja Kuittinen
| Sociétés | Poste | Début |
|---|---|---|
| Primus International Oy Ltd. | Directeur Général | 30/11/2010 |
Aplagon Oy
 Aplagon Oy Financial ConglomeratesFinance Aplagon Oy provides pharmaceutical discovery and development services. It develops locally acting antithrombotic products (APACs). The company was founded by Riitta Lassila and Yrjo Sakari Lassila in 2009 and is headquartered in Helsinki, Finland. | Directeur/Membre du Conseil | - |
Anciens postes connus de Arja Kuittinen
| Sociétés | Poste | Fin |
|---|---|---|
| Hoechst Marion Roussel SA | Corporate Officer/Principal | - |
Addoz Oy
 Addoz Oy Medical SpecialtiesHealth Technology Addoz Oy provides medical dosage apparatus. The firm develops and manufactures dispensing systems for tablet and capsule form medication. It offers Med-O-Wheel, a medication dispenser developed for dosage of medication and vitamins. The company was founded in June 1999 and is headquartered in Forssa, Finland. | Corporate Officer/Principal | - |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Directeur Technique/Scientifique/R&D | - |
Lallemand Finland Oy
 Lallemand Finland Oy BiotechnologyHealth Technology Lallemand Finland Oy develops, manufactures and markets biological pesticides and growth promoters. It offers products and services to forestry, horticulture and amenity sectors. The company's products include Rotstop, Turf Mark Dye Tablet, Mycostop, Mycostop Mix, and GlioMix. Verdera was founded in 2002 and is headquartered in Espoo, Finland. | Corporate Officer/Principal | - |
Hermo Pharma Oy
 Hermo Pharma Oy Pharmaceuticals: MajorHealth Technology Hermo Pharma Ltd. is a biopharmaceutical company which aims to discover and develop cutting-edge therapeutic approaches for currently untreatable medical needs, particularly in the field of neurology. The company's R&D programs are based on scientifically innovative concepts. These concepts are being developed through preclinical and early clinical development phases with the aim gaining partners prior to late clinical development phases and finally marketing. The company was founded in 2008 by professors Mart Saarma, Eero Castrén, Heikki Rauvala and Dr. Henri Huttunen. The company operates in close collaboration with several academic laboratories affiliated with the University of Helsinki. Hermo Pharma Ltd. operates according to the 'virtual business model'. This means the company outsources the majority of business functions outside of its core business areas, while controlling the key technology assets and strategic partnerships with a small but highly capable group of people managing operations. As the company's overheads are kept lower than traditional biopharmaceutical companies much more of its financial resources can be utilized directly to achieve business goals. Hermo Pharma Ltd. is a privately owned, venture capital backed company. Its current investors include Helsinki University Funds and Seed Fund Vera Ltd. | Président | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
| Hoechst Marion Roussel SA | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
Lallemand Finland Oy
Lallemand Finland Oy BiotechnologyHealth Technology Lallemand Finland Oy develops, manufactures and markets biological pesticides and growth promoters. It offers products and services to forestry, horticulture and amenity sectors. The company's products include Rotstop, Turf Mark Dye Tablet, Mycostop, Mycostop Mix, and GlioMix. Verdera was founded in 2002 and is headquartered in Espoo, Finland. | Health Technology |
Addoz Oy
Addoz Oy Medical SpecialtiesHealth Technology Addoz Oy provides medical dosage apparatus. The firm develops and manufactures dispensing systems for tablet and capsule form medication. It offers Med-O-Wheel, a medication dispenser developed for dosage of medication and vitamins. The company was founded in June 1999 and is headquartered in Forssa, Finland. | Health Technology |
Hermo Pharma Oy
Hermo Pharma Oy Pharmaceuticals: MajorHealth Technology Hermo Pharma Ltd. is a biopharmaceutical company which aims to discover and develop cutting-edge therapeutic approaches for currently untreatable medical needs, particularly in the field of neurology. The company's R&D programs are based on scientifically innovative concepts. These concepts are being developed through preclinical and early clinical development phases with the aim gaining partners prior to late clinical development phases and finally marketing. The company was founded in 2008 by professors Mart Saarma, Eero Castrén, Heikki Rauvala and Dr. Henri Huttunen. The company operates in close collaboration with several academic laboratories affiliated with the University of Helsinki. Hermo Pharma Ltd. operates according to the 'virtual business model'. This means the company outsources the majority of business functions outside of its core business areas, while controlling the key technology assets and strategic partnerships with a small but highly capable group of people managing operations. As the company's overheads are kept lower than traditional biopharmaceutical companies much more of its financial resources can be utilized directly to achieve business goals. Hermo Pharma Ltd. is a privately owned, venture capital backed company. Its current investors include Helsinki University Funds and Seed Fund Vera Ltd. | Health Technology |
| Primus International Oy Ltd. | |
Aplagon Oy
Aplagon Oy Financial ConglomeratesFinance Aplagon Oy provides pharmaceutical discovery and development services. It develops locally acting antithrombotic products (APACs). The company was founded by Riitta Lassila and Yrjo Sakari Lassila in 2009 and is headquartered in Helsinki, Finland. | Finance |
